Hancock Whitney’s Chembio diagnostics, Inc. CEMI Stock Holding History

Hancock Whitney’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-14,164	Closed	-$46K	–	849
2020 Q2	$46K	Buy	+14,164	New	+$134K	﹤0.01%	775

Other funds holding CEMI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Hancock Whitney's CEMI Position: Q3 2020 in Review

Hancock Whitney sold out of Chembio diagnostics, Inc. (CEMI) in Q3 2020, closing a stake of 14,164 shares — an estimated $46K sold.

Hancock Whitney first reported a position in CEMI in Q2 2020 and held it in 1 quarter. The position peaked at $46K in Q2 2020. 59 funds tracked by Wall St. Rank hold CEMI as of Q3 2020.

Hancock Whitney reported no remaining Chembio diagnostics, Inc. position as of Q3 2020 after selling out during the quarter.
Hancock Whitney sold 14,164 Chembio diagnostics, Inc. shares in Q3 2020, an estimated $46K.
Hancock Whitney first reported a position in Chembio diagnostics, Inc. in Q2 2020 and held it in 1 quarter.
Hancock Whitney's Chembio diagnostics, Inc. position peaked at $46K in Q2 2020.
59 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q3 2020.

Based on Hancock Whitney's 13F filing for Q3 2020, filed 5 Nov 2020.